ResMed Inc. Price Today
ResMed Inc.
RMD
Healthcare
$26.34B
💰
Market Cap
30.6
💸
Price to Earnings
$5.8
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
7 |
Strong Buy |
5 |
Hold |
7 |
Sell |
0 |
Strong Sell |
0 |
RMD Price Forecast Target
179.2 👉 290.0 +62%
RMD EPS Forecast
5.8 👉 7.4 +26%
Financials
Profit Margin
21 %
Revenue Growth
22.7 %
Dividend
$ 1.92
Held Percent
1.3% - Insiders
66.8% - Institutions
31.9% - Public
Major Fund Holders
-
💰 Vanguard Group Inc $3.8B
-
💰 Blackrock Inc. $2.9B
-
💰 FMR, LLC $1.4B
-
💰 State Street Corporation $1.4B
-
💰 Capital World Investors $930.6M
Stock Ideas
Bruce Berkowitz Portfolio
Bruce Berkowitz, the esteemed founder of Fairholme, has established himself as a prominent figure in the investment world with his exceptional portfolio strategy. Since its inception in 1999, Fairholme has grown into a formidable $19 billion mutual …
Ken Griffin Portfolio
Ken Griffin, the visionary founder of Citadel Investment Group, has transformed portfolio strategy with his innovative and tech-driven approach. Starting as a college student trading stock options, Griffin quickly rose to success and attracted signi…
David Shaw Portfolio
David Shaw is a renowned computer scientist, technological pioneer, and founder of D.E. Shaw Group, one of the earliest quantitative hedge funds. Shaw pioneered the use of algorithmic and computational modeling in institutional investing. While litt…
Stanley Druckenmiller Portfolio
Stanley Druckenmiller is a legendary hedge fund manager who has made billions of dollars for his investors. His current portfolio is heavily invested in gold, silver, and other precious metals. He also owns shares in several technology and healthcar…📮FAQ
Some Frequently Asked Questions.
The ResMed Inc. industry is Medical Instruments & Supplies
The ResMed Inc. sector is Healthcare
The ResMed Inc. forecasted predicted Price to Earnings PE ratio is 24.2
The ResMed Inc. Price to Earnings PE ratio is 30.6
The Market Capitalization of ResMed Inc. is $26.34B
There are total of 145656581 float shares with 66.8% held by Institutions and 1.3% held by insiders
The MResMed Inc. forecasted Earnings per Share EPS is $7.4
The ResMed Inc. Earnings per Share EPS is 5.8
The ResMed Inc. company has $2386058000 gross profits with 21 profit margins
The ResMed Inc. Earnings Growth is 0.172% with 0.177% quarterly earnings growth
The ResMed Inc. Revenue is $4222992896 with 0.227 revenue growth
The price target for ResMed Inc. stock is $290.0 for the high target and $221.0 for the low target
The consensus analyst recommendations for ResMed Inc. is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for ResMed Inc. is Buy, with the following breakdown:
- Buy: 7
- Strong Buy: 5
- Hold: 7
- Sell: 0
- Strong Sell: 0
The Beta of ResMed Inc. is 0
The dividend of ResMed Inc. is $1.92
The dividend yield of ResMed Inc. is 0.0107%
The biggest institutional and mutual fund holders of ResMed Inc. stock are
- Vanguard Group Inc
- Blackrock Inc.
- FMR, LLC
- State Street Corporation
The ResMed Inc. ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0